Monoclonal Rat anti‑Human IL2RA / CD25 Antibody (clone YTH 906.9HL, PE, WB) LS‑C348133
Monoclonal Rat anti‑Human IL2RA / CD25 Antibody (clone YTH 906.9HL, PE, WB) LS‑C348133
Antibody:
IL2RA / CD25 Rat anti-Human Monoclonal (PE) (YTH 906.9HL) Antibody
Format:
Phycoerythrin, Unmodified
Overview
Antibody:
IL2RA / CD25 Rat anti-Human Monoclonal (PE) (YTH 906.9HL) Antibody
Format:
Phycoerythrin, Unmodified
Specifications
Description
CD25 antibody LS-C348133 is a PE-conjugated rat monoclonal antibody to human CD25 (IL2RA). Validated for Flow and WB.
Target
Human IL2RA / CD25
Synonyms
IL2RA | CD25 antigen | CD25 | IDDM10 | IL-2 receptor subunit alpha | IL2R | Interleukin 2 receptor, alpha | IL-2-RA | IL2-RA | TCGFR | IL-2R subunit alpha | p55 | TAC antigen
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG2b
Monoclonal
Conjugations
Phycoerythrin
Purification
Protein G purified
Immunogen
Activated human T lymphocytes.
Applications
- Western blot
- Flow Cytometry
Usage
This antibody is suitable for use in Flow Cytometry. The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.
Presentation
PBS, 0.02% Sodium Azide, BSA
Storage
Store at 4°C. Do not freeze.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
IHC, IHC - Paraffin, IHC - Frozen, Western blot, ELISA
Species:
Human
Applications:
IHC, IHC - Paraffin, IHC - Frozen
Species:
Human, Monkey, Mouse, Rat
Applications:
IHC, IHC - Paraffin, Immunofluorescence, Western blot, ELISA
Species:
Human
Applications:
IHC, Flow Cytometry
Species:
Human
Applications:
Immunofluorescence, Western blot, Peptide Enzyme-Linked Immunosorbent Assay
Species:
Human
Applications:
Western blot
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 9/26/2024